调整心力衰竭的指导方针导向医疗治疗与减少喷射分数:一个实用指南
Agnieszka Kapłon-Cieślicka1, Panagiotis Vardas2,3, Marcin Grabowski4
11st Chair and Department of Cardiology, Medical University of Warsaw, Warszawa, Poland. agnieszka.kaplon@gmail.com.
Kardiologia polska
|October 5, 2023
概括
通过减少喷射率 (HFrEF) 管理心力衰竭涉及四个关键药物类别. 这项研究提供了克服常见挑战和维持拯救生命的HFrEF治疗的策略.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 内部医学 内部医学
背景情况:
- 2021年欧洲心脏病学会的指导方针推四种类型的药物治疗心力衰竭与减少喷射率 (HFrEF).
- 在临床实践中,由于不耐受性和不良事件,达到所有四种药物类别 (SGLT2 抑制剂,β 抑制剂,MRA,ACE 抑制剂/RNAI) 的目标剂量往往是具有挑战性的.
- 优化HFrEF药物治疗需要策略来管理常见的复杂化因素.
研究的目的:
- 为启动和修改HFrEF治疗提供实用策略.
- 为应对管理症状性低血压,心房动,病或高胆血症的HFrEF患者所面临的挑战.
- 确保在复杂的HFrEF病例中继续进行指导方针导向的医疗治疗.
主要方法:
- 对HFrEF管理的当前指导方针和临床证据的审查.
- 为特定具有挑战性的临床场景开发治疗算法.
- 专注于剂量定位和药物组合策略.
主要成果:
- 该研究概述了安全启动或调整HFrEF药物的方法.
- 介绍了治疗病和心房动等并发病患者的策略.
- 这些方法旨在防止降低剂量或停止必要的HFrEF治疗.
结论:
- 有效管理HFrEF需要量身定制的策略来克服治疗障碍.
- 维持指导方针导向的医疗治疗对于改善HFrEF患者的治疗结果至关重要.
- 这项工作支持临床医生优化复杂的HFrEF患者的药物治疗.
相关概念视频
Heart Failure V: Medical Management
10
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
10
Heart Failure VI: Adjunct Therapies
16
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
445
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
445
Rheumatic Heart Disease III: Medical Management
11
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
11
Heart Failure IV: Classification and Diagnostic Evaluation
19
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
19
Mitral Regurgitation IV: Nursing Management
40
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
40


